Phenelzine
- Generic Name
- Phenelzine
- Brand Names
- Nardil
- Drug Type
- Small Molecule
- Chemical Formula
- C8H12N2
- CAS Number
- 51-71-8
- Unique Ingredient Identifier
- O408N561GF
- Background
Phenelzine, with the formula β-phenylethylhydrazine, is a monoamine oxidase inhibiting antidepressant that is effective in the treatment of panic disorder and social anxiety disorder. It was developed by Parke Davis and originally FDA approved on June 9th, 1961. It is currently approved under prescription by the name of Nardil.
- Indication
Phenelzine is indicated for the treatment of nonendogenous, neurotic or atypical depression for patients that do not tolerate other forms of therapy.
...
- Associated Conditions
- Exogenous depression, Neurotic depression, Atypical Depressive disorder
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath